Screening and detection of heterogenous vancomycin intermediate Staphylococcus aureus in Hospital Kuala Lumpur Malaysia, using the glycopeptide resistance detection Etest and population analysis profiling.
In a 3-month study done in Hospital Kuala Lumpur (HKL), 7 out of 320 methicillin resistant Staphylococcus aureus isolates were confirmed as heterogeneous vancomycin intermediate S. aureus (hVISA) using the glycopeptide resistance detection e-test and population analysis, giving a prevalence rate of 2.19%. This is the first report of hVISA in Malaysia.
Department of Microbiology and Immunology, University Kebangsaan Malaysia Medical Centre; ; Institute for Medical Research, MalaysiaJalan Pahang;
Siti Roszilawati
SR
Ramli
UKM Medical Molecular Biology Institute,University Kebangsaan Malaysia;
Hui-Min
HM
Neoh
Department of Pathology,Hospital Kuala Lumpur, Malaysia.
Muhammad Nazri
MN
Aziz
Department of Microbiology and Immunology, University Kebangsaan Malaysia Medical Centre;
Salasawati
S
Hussin
Hospital Kuala Lumpur.; heterogenous vancomycin intermediate Staphylococcus aureus (hVISA)